581 related articles for article (PubMed ID: 16316970)
1. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
[TBL] [Abstract][Full Text] [Related]
2. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
Zhang L; Zhang ZG; Liu X; Hozeska A; Stagliano N; Riordan W; Lu M; Chopp M
Thromb Haemost; 2006 Jan; 95(1):166-73. PubMed ID: 16543976
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection.
Liu XS; Zhang ZG; Zhang L; Morris DC; Kapke A; Lu M; Chopp M
J Cereb Blood Flow Metab; 2006 Jun; 26(6):787-96. PubMed ID: 16177809
[TBL] [Abstract][Full Text] [Related]
4. FK-506 extended the therapeutic time window for thrombolysis without increasing the risk of hemorrhagic transformation in an embolic rat stroke model.
Okubo S; Igarashi H; Kanamatsu T; Hasegawa D; Orima H; Katayama Y
Brain Res; 2007 Apr; 1143():221-7. PubMed ID: 17316578
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke--an MRI study.
Kollmar R; Henninger N; Bardutzky J; Schellinger PD; Schäbitz WR; Schwab S
Exp Neurol; 2004 Nov; 190(1):204-12. PubMed ID: 15473993
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.
Tanaka N; Katayama Y; Katsumata T; Otori T; Nishiyama Y
Brain Res; 2007 Sep; 1169():125-32. PubMed ID: 17706949
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke.
Zhang L; Zhang ZG; Zhang R; Morris D; Lu M; Coller BS; Chopp M
Circulation; 2003 Jun; 107(22):2837-43. PubMed ID: 12756151
[TBL] [Abstract][Full Text] [Related]
9. Treatment with melagatran alone or in combination with thrombolytic therapy reduced ischemic brain injury.
Wang CX; Ding X; Shuaib A
Exp Neurol; 2008 Sep; 213(1):171-5. PubMed ID: 18598697
[TBL] [Abstract][Full Text] [Related]
10. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.
Alonso de Leciñana M; Gutiérrez M; Roda JM; Carceller F; Díez-Tejedor E
J Neurol Sci; 2006 Sep; 247(2):121-9. PubMed ID: 16797595
[TBL] [Abstract][Full Text] [Related]
11. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model.
Lu HT; Zhao JG; Li MH; Li YD
Brain Res; 2012 Feb; 1438():75-84. PubMed ID: 22227456
[TBL] [Abstract][Full Text] [Related]
12. Serum S100B indicates successful combination treatment with recombinant tissue plasminogen activator and MK-801 in a rat model of embolic stroke.
Tanaka Y; Marumo T; Omura T; Yoshida S
Brain Res; 2007 Jun; 1154():194-9. PubMed ID: 17475227
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model.
Maeda M; Furuichi Y; Noto T; Matsuoka N; Mutoh S; Yoneda Y
Brain Res; 2009 Feb; 1254():99-108. PubMed ID: 19101526
[TBL] [Abstract][Full Text] [Related]
14. [Prospects of thrombolytic therapy for acute ischemic stroke].
Nakashima T; Minematsu K
Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
[TBL] [Abstract][Full Text] [Related]
15. MRI of combination treatment of embolic stroke in rat with rtPA and atorvastatin.
Ding G; Jiang Q; Li L; Zhang L; Zhang ZG; Panda S; Ewing JR; Chopp M
J Neurol Sci; 2006 Jul; 246(1-2):139-47. PubMed ID: 16626754
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells.
Thum T; Fraccarollo D; Galuppo P; Tsikas D; Frantz S; Ertl G; Bauersachs J
Cardiovasc Res; 2006 Apr; 70(1):50-60. PubMed ID: 16480696
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia.
Cimino M; Balduini W; Carloni S; Gelosa P; Guerrini U; Tremoli E; Sironi L
Neurotoxicology; 2005 Oct; 26(5):929-33. PubMed ID: 15923039
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sonothrombolysis in a rat model of embolic ischemic stroke.
Daffertshofer M; Huang Z; Fatar M; Popolo M; Schroeck H; Kuschinsky W; Moskowitz MA; Hennerici MG
Neurosci Lett; 2004 May; 361(1-3):115-9. PubMed ID: 15135907
[TBL] [Abstract][Full Text] [Related]
19. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging indexes of therapeutic efficacy of recombinant tissue plasminogen activator treatment of rat at 1 and 4 hours after embolic stroke.
Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Jiang P; Divine GW; Knight RA; Chopp M
J Cereb Blood Flow Metab; 2000 Jan; 20(1):21-7. PubMed ID: 10616789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]